A. Peer

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database

Daniel Keizman, M Ø Fosboel, Hermann Reichegger et al. · Prostate Cancer and Prostatic Diseases · 2017 · 46 citations

Engineering, Oncologic Imaging, Medical Imaging +13

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Oliver Sartor, Daniel Heinrich, Neil Mariados et al. · Annals of Oncology · 2017 · 33 citations · Full text

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

Cora N. Sternberg, Farid Saad, Julie N. Graff et al. · Annals of Oncology · 2020 · 19 citations · Full text

Binding of Drugs in Serum, Blood Cells and Tissues of Rabbits with Experimental Acute Renal Failure

A. Peer, K.M. Belpaire, Marc G. Bogaert · Pharmacology · 1981 · 11 citations

1772MO Pembrolizumab (pembro) plus enzalutamide (enza) and androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): Randomized double-blind phase III KEYNOTE-991 study

Christian Gratzke, Mustafa Özgüroğlu, A. Peer et al. · Annals of Oncology · 2023 · 11 citations · Full text